SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is a major talking point as investors eagerly await its business update call, expecting Dr. PSS to reveal breakthroughs in Anktiva's global strategy and the BioShield platform, while simultaneously navigating intense community chatter around perceived short interest manipulation.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Indonesia Energy Corp Ltd (INDO) is trending amidst intense community debate following a steep sell-off, with many questioning potential dilution and market manipulation as the stock paradoxically plummets despite surging crude oil prices and escalating Middle East tensions driving other small-cap energy plays higher.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

Crowdstrike is trending after delivering a double beat on earnings with solid guidance, reinforcing its position as a cybersecurity leader amidst increasing global cyber threats. The community is actively discussing whether AI is a tailwind or a threat to the sector, with many viewing recent dips as a buying opportunity given the crucial and growing demand for advanced security solutions.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin (WEEDCOIN CRYPTO) is seeing strong community interest and positive momentum, largely driven by enthusiasm for the approaching 4/20 cannabis culture event. Investors are discussing its potential as a "culture coin" on the Solana blockchain, citing its consistent development and unique position within the expanding cannabis ecosystem.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is experiencing significant bullish momentum driven by an EU regulatory recommendation for its combined COVID-19/flu vaccine, the FDA's decision to review its standalone flu shot, and positive long-term data from its personalized cancer vaccine collaboration with Merck. These developments are fueling strong community discussions around potential short squeezes and the company's expanding mRNA pipeline beyond COVID-19, including its integration of AI for drug discovery.

GitLab, Inc. engages in the intelligent DevSecOps platform for software innovation. The firm enables organizations to increase developer productivity, improve operational efficiency, reduce security and compliance risk, and accelerate digital transformation. The company was founded by Dmitriy Zaporozhets and Sid Sijbrandij in 2011 and is headquartered in San Francisco, CA.

Gitlab Inc - Ordinary Shares - Class A

Gitlab Inc

Gitlab is trending as investors react to its latest financial report, which, despite beating recent revenue and EPS figures, presented weaker-than-anticipated forward guidance, sparking a polarized discussion about its growth trajectory and high stock-based compensation amid broader software sector concerns and persistent buyout speculation.

Kraken Robotics, Inc. engages in the design, manufacture, and sale of software-centric sensors, subsea batteries, thrusters and underwater robotic systems. It operates through the following geographical segments: Asia Pacific, Europe, Middle East and Africa, North America, and Other. The company was founded on May 14, 2008, and is headquartered in Mt. Pearl, Canada.

Kraken Robotics Inc

Kraken Robotics is trending following its strategic acquisition of Covelya Group, a "company-maker" deal that significantly expands its subsea technology offerings and market reach as a global prime contractor. The community is discussing the long-term bullish implications of this vertical integration and significant battery orders, alongside short-term concerns regarding share dilution.

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

Rigel Pharmaceuticals is trending following a strong quarterly earnings beat and robust 2026 outlook, which confirmed its profitability and growing cash position. The community is buzzing about the company's compelling valuation, high short interest, and the increasing speculation around a potential share buyback or acquisition, fueled by its expanding product portfolio and key Eli Lilly partnership.

Hut 8 Corp. engages in the development and operation of data centers at scale, supporting AI, high-performance computing (HPC), ASIC compute, and other energy-intensive technology applications. It operates through the following segments: Power, Digital Infrastructure, Compute, and Others. The Power segment manages the origination, development, and management of powered land and energy infrastructure. The Digital Infrastructure refers to the development, ownership, and operation of facilities designed to support next-generation, energy-intensive technology application. The Compute segment deals with operating businesses that deploy and monetize compute assets across next-generation energy-intensive technology. The Others segment offers equipment sales and repairs. The company was founded on January 27, 2023 and is headquartered in Miami, FL.

Hut 8 Corp

Hut 8 Corp. is a focal point for investors as its strategic pivot into AI and high-performance computing data centers, highlighted by a major Anthropic partnership, drives significant analyst upgrades and bullish long-term sentiment, despite recent earnings results drawing mixed interpretations and ongoing community debate over short-term price volatility and market manipulation.

Ross Stores, Inc. engages in the operation of off-price retail apparel and home accessories stores. Its products include branded and designer apparel, accessories, footwear, and home fashions through the Dress for Less and dd's DISCOUNTS brands. The company was founded by Stuart G. Moldaw in 1957 and is headquartered in Dublin, CA.

Ross Stores, Inc.

Ross Stores is trending after reporting a significant Q4 earnings beat and robust Q1 sales outlook, fueled by strong customer response and operational improvements, though community conversation remains divided on whether the future guidance justifies its current valuation amidst a value-seeking consumer environment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Taser 2.0? Sandisk Builds Back-to-Back High Tight Flags

With its back-to-back high tight flags and its explosive fundamental catalysts, Sandisk is following the historic path of Taser in 2003.

Champlain Investment Partners LLC Decreases Position in Axon Enterprise, Inc $AXON

Champlain Investment Partners LLC trimmed its position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 5.5% during the 3rd quarter, according to the company in its most recent filing with the...

American Century Companies Inc. Has $116.11 Million Stake in Axon Enterprise, Inc $AXON

American Century Companies Inc. lowered its stake in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 66.5% in the third quarter, according to its most recent Form 13F filing with the Securities...

Erste Asset Management GmbH Sells 10,913 Shares of Axon Enterprise, Inc $AXON

Erste Asset Management GmbH lowered its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 94.8% during the third quarter, according to its most recent disclosure with the...

Integrated Advisors Network LLC Sells 3,258 Shares of Axon Enterprise, Inc $AXON

Integrated Advisors Network LLC trimmed its stake in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 70.9% in the 3rd quarter, according to the company in its most recent filing with the...

APG Asset Management N.V. Cuts Stock Position in Axon Enterprise, Inc $AXON

APG Asset Management N.V. decreased its position in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 9.4% in the third quarter, according to its most recent Form 13F filing with the...

Axon Enterprise, Inc $AXON Shares Bought by Rafferty Asset Management LLC

Rafferty Asset Management LLC lifted its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 10.8% during the third quarter, according to its most recent disclosure with the...

Cache Advisors LLC Has $648,000 Stake in Axon Enterprise, Inc $AXON

Cache Advisors LLC cut its stake in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 77.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange...

Axon Enterprise, Inc (NASDAQ:AXON) Given Average Rating of "Moderate Buy" by Brokerages

Axon Enterprise, Inc (NASDAQ:AXON - Get Free Report) has earned a consensus rating of "Moderate Buy" from the nineteen brokerages that are currently covering the firm, MarketBeat.com reports. Three...

DNB Asset Management AS Has $19.57 Million Holdings in Axon Enterprise, Inc $AXON

DNB Asset Management AS increased its position in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 24.6% during the third quarter, according to the company in its most recent disclosure...

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Current Price	$579.09
Prev Close	$572.02
Open	$569.14
Dividend Yield	0.00%
50-Day Moving Average	$539.01
Beta	1.13
Avg. Volume	1.44M
PE Ratio	375.07

52-Week High	$885.92
52-Week Low	$396.41
Market Capitalization	$57.56B
EPS (Annual)	$1.51
Price to Book	14.15
Revenue Per Employee	$441,196.19

AXON
Axon Enterprise Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AXON News

AXONAxon Enterprise Inc